Note: Ingredients listed on restricted chemical lists
EC/CAS
231-633-2/7664-38-2
Name of the chemical
phosphoric acid
Concentration
<0,1
EC/CAS
203-234-3/104-76-7
Name of the chemical
2-ethyl-1-hexanol
Concentration
<0,1 <0,01
EC/CAS
247-500-7/55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
<0,01
EC/CAS
220-239-6
Name of the chemical
Mixture of 5-Chloro-2-methyl-isothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one 2-Methyl-2H-isothiazol-3-one
Concentration
0,6 %
General Information
Version
1.0
Revision date
2022-05-24
Product name
Retaflame Ltd
Substance name
mixture
1.2.1 Relevant identified uses
Wood protection
1.2.2. Uses advised against
The product should not be used in ways other then those referred in Section 1
Manufacturer Name
Retaflame Ltd
Icons in SDS
Company Information
company name
11e, Tallinn, 12915
e-mail address of the competent person responsible for the Safety Data Sheet
retaflame@retaflame.ee
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification of the mixture in accordance with
Hazard pictograms
1.0
Signal word
Warning Hazardous substances reaction mass of: 5-chloro-2- methyl-4-isothiazolin-3-one [EC no. 247-500-7]and 2- methyl-2H -isothiazol-3one [EC no. 220-239-6] (3:1) Hazard statements H317 May cause an allergic skin reaction.
Precautionary statements
P101 If medical advice is needed, have product container or label at hand. P102 Keep out of reach of children. P280 Wear protective gloves. P333+P313 If skin irritation or rash occurs: Get medical advice/attention. P362+P364 Take off contaminated clothing and wash it before reuse. P501 Dispose of contents/container to by handing over to the person authorized to dispose of waste or by returning to the supplier.
2.3 Other hazards
The mixture does not contain substances with endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605. Mixture does not contain any substance meet the criteria for PBT or vPvB in accordance with Annex XIII of